PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsCancer concern over stem cells

BioNews

Cancer concern over stem cells

Published 9 June 2009 posted in News and appears in BioNews 305

Author

BioNews

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).

Stem cells can turn cancerous if they are grown for too long in the laboratory, two new studies show. A report in New Scientist highlights two articles which show that adult stem cells can become immortal, a key feature of cancer cells. The scientists stress that current trials using injections...

Stem cells can turn cancerous if they are grown for too long in the laboratory, two new studies show. A report in New Scientist highlights two articles which show that adult stem cells can become immortal, a key feature of cancer cells. The scientists stress that current trials using injections of bone marrow stem cells should be safe, since these cells are only briefly grown outside the body. However, they say that more research needs to be done to establish a safe time limit for growing stem cells destined to be used in therapies.


Many scientists believe that stem cells derived from very early human embryos - the body's 'master' cells capable of growing into any type of tissue - could lead to new treatments for a range of diseases. However, it has long been known from animal studies that such embryo stem cells (ES cells) have the potential to form cancers called teratomas when injected into the body.  Now, a team at the Autonomous University of Madrid in Spain has shown that adult stem cells could also form cancers, if they are grown outside the body for a long time.


The scientists grew human mesenchymal stem cells, extracted from fat cells, for up to eight months in the laboratory. During this time, the cells divided and multiplied between 90 and 140 times. When injected into animals, the cells  became cancerous, the team reported in the journal Cancer Research. However, current clinical trials using injections of bone marrow cells to treat heart muscle damage should be safe, since these stem cells are only grown outside the body for a short time.


Stem cells probably become cancerous when they switch on production of a protein called telomerase to repair the cells' telomeres - protective pieces of DNA at the ends chromosomes, which usually shorten every time a cell divides and copies its genetic information. This mechanism acts as a biological 'clock', limiting the number of times a cell can divide and multiply. However, telomerase overrides this clock, by restoring telomeres to their original length. In a second study,  also published in Cancer Research, a team of Danish researchers found that artificially switching on telomerase production in mesenchymal stem cells eventually turns them into immortal cancer cells.


The scientists, based at the University Hospital of Odense, say that although their experiment is an artificial situation, switching on telomerase is 'clearly sufficient for them to acquire the ability to become tumorigenic'. Team leader Jorge Burns says that 'we need to know where to draw the line between safe and unsafe expansion of cells even in non-telomerase-producing cells'. Chris Higgins, of the UK's Medical Research Council Clinical Science Centre, said that stem cell lines maintained and developed in stem cell banks are currently only used for research purposes. 'Stem cells can potentially be of enormous benefit for clinical treatment but as with the development of all drugs and therapies, there are safety issues that need to be investigated and resolved', he said.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
27 November 2020 • 2 minutes read

Stem cells protect chromosome ends to prevent ageing

by Emma Lamb and 1 others

Chromosome ends are protected differently in stem cells compared to adult cells...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Washington state delays vote on stem cell research

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856